Patents Assigned to Seren Pharmaceuticals Inc.
  • Anti-fungal agent
    Patent number: 12121512
    Abstract: An object of the present invention is to provide an antifungal agent which is effective against cryptococcosis. The present invention provides an antifungal agent comprising ravuconazole as an active ingredient, wherein the agent is administered to an animal suffering from cryptococcosis. Further, the present invention provides an antifungal agent comprising ravuconazole as an active ingredient, wherein the agent is administered to an animal suffering from cryptococcus that is resistant to triazole-based antifungal agents selected from the group consisting of fluconazole, itraconazole and voriconazole.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: October 22, 2024
    Assignees: SEREN PHARMACEUTICALS INC., NIHON UNIVERSITY
    Inventors: Rui Kano, Osamu Ogawa
  • NOVEL THERAPEUTIC AGENT FOR PROTOTHECA DISEASE
    Publication number: 20220378752
    Abstract: The present invention has an object of providing a composition that is effective for the treatment of a prototheca disease. According to the present invention, a composition containing ravuconazole as an active ingredient, which is administered to an animal suffering from a prototheca disease caused by Prototheca wickerhamii or Prototheca zopfii, is provided.
    Type: Application
    Filed: July 9, 2020
    Publication date: December 1, 2022
    Applicants: SEREN PHARMACEUTICALS INC., NIHON UNIVERSITY
    Inventors: Rui KANO, Osamu OGAWA
  • ANTI-FUNGAL AGENT
    Publication number: 20220142987
    Abstract: An object of the present invention is to provide an antifungal agent which is effective against cryptococcosis. The present invention provides an antifungal agent comprising ravuconazole as an active ingredient, wherein the agent is administered to an animal suffering from cryptococcosis. Further, the present invention provides an antifungal agent comprising ravuconazole as an active ingredient, wherein the agent is administered to an animal suffering from cryptococcus that is resistant to triazole-based antifungal agents selected from the group consisting of fluconazole, itraconazole and voriconazole.
    Type: Application
    Filed: April 6, 2020
    Publication date: May 12, 2022
    Applicants: SEREN PHARMACEUTICALS INC., NIHON UNIVERSITY
    Inventors: Rui Kano, Osamu Ogawa
  • Dosing regimens for the treatment of fungal infections
    Patent number: 11324728
    Abstract: Described herein are dosing regimens for the treatment of fungal infections such as onychomycosis using ravuconazole or a salt, solvate or prodrug thereof.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 10, 2022
    Assignee: Seren Pharmaceuticals Inc.
    Inventors: Osamu Ogawa, Hideyo Yamaguchi
  • DOSING REGIMENS FOR THE TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20200316033
    Abstract: Described herein are dosing regimens for the treatment of fungal infections such as onychomycosis using ravuconazole or a salt, solvate or prodrug thereof.
    Type: Application
    Filed: November 28, 2018
    Publication date: October 8, 2020
    Applicant: Seren Pharmaceuticals Inc.
    Inventors: Osamu Ogawa, Hideyo Yamaguchi